abrdn Life Sciences Investors Q1 2025 Commentary
Source: SeekingAlpha
2025-05-31 00:20:00 ET
Summary
- The equity portion of the Fund fell (gross of fees) and underperformed its benchmark, the NASDAQ Biotechnology Index.
- During the first quarter of 2025, we made several changes to the portfolio.
- With Donald Trump securing his second term, uncertainty around election results has been replaced with policy ambiguity.
Fund performance
Read the full article on Seeking Alpha
For further details see:
abrdn Life Sciences Investors Q1 2025 Commentary
Aberdeen Total Dynamic Dividend Fund
NASDAQ: AOD
AOD Trading
-0.2% G/L:
$9.7052 Last:
320,880 Volume:
$9.77 Open:
AOD Latest News
March 10, 2026 04:17:00 pm
Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
January 12, 2026 04:17:00 pm
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
June 10, 2025 04:17:00 pm
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS
